Medigene Ag Stock Shares Outstanding
Medigene AG fundamentals help investors to digest information that contributes to Medigene's financial success or failures. It also enables traders to predict the movement of Medigene Pink Sheet. The fundamental analysis module provides a way to measure Medigene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medigene pink sheet.
Medigene |
Medigene AG Company Shares Outstanding Analysis
Medigene's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Medigene Shares Outstanding | 24.56 M |
Most of Medigene's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medigene AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Medigene AG has 24.56 M of shares currently outstending. This is 86.39% lower than that of the Healthcare sector and 77.01% lower than that of the Biotechnology industry. The shares outstanding for all United States stocks is 95.7% higher than that of the company.
Medigene Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medigene's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Medigene could also be used in its relative valuation, which is a method of valuing Medigene by comparing valuation metrics of similar companies.Medigene is currently under evaluation in shares outstanding category among its peers.
Medigene Fundamentals
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0887 | |||
| Profit Margin | 0.31 % | |||
| Operating Margin | 0.32 % | |||
| Current Valuation | 30.5 M | |||
| Shares Outstanding | 24.56 M | |||
| Shares Owned By Insiders | 6.66 % | |||
| Shares Owned By Institutions | 4.62 % | |||
| Price To Earning | 5.26 X | |||
| Price To Book | 0.92 X | |||
| Price To Sales | 1.86 X | |||
| Revenue | 10.46 M | |||
| Gross Profit | 9.1 M | |||
| EBITDA | (6.49 M) | |||
| Net Income | (9.98 M) | |||
| Cash And Equivalents | 39.38 M | |||
| Cash Per Share | 1.60 X | |||
| Total Debt | 3.73 M | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 6.04 X | |||
| Book Value Per Share | 2.41 X | |||
| Cash Flow From Operations | (10.75 M) | |||
| Earnings Per Share | 0.42 X | |||
| Price To Earnings To Growth | (0.36) X | |||
| Target Price | 18.82 | |||
| Number Of Employees | 61 | |||
| Beta | 0.88 | |||
| Market Capitalization | 56.49 M | |||
| Total Asset | 59.47 M | |||
| Z Score | 9.0 | |||
| Net Asset | 59.47 M |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Medigene Pink Sheet
If you are still planning to invest in Medigene AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigene's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |